EGFR and head and neck squamous cell carcinoma: Nanobody‐targeted PDT remains therapeutic in tumor head and neck squamous cell carcinoma (HNSCC) organoids with low EGFR expression levels, whereas the corresponding normal organoids did not respond to EGFR‐targeted PDT.188